Categories AlphaGraphs, Earnings, Health Care

Merck (MRK) Q1 Earnings: Key quarterly numbers that you need to note down

Lowers 2020 full-year revenue & EPS guidance

Merck (NYSE: MRK) today reported first quarter financial results for the period ended March 31, 2020.

On GAAP basis, first quarter EPS was $1.26 vs. $1.12 in the first quarter of 2019. Non-GAAP EPS was $1.50, compared to $1.22 in the first quarter of 2019.

Total sales increased 11% to $12.05 billion.

Shares down nearly 2% during the pre-market hours following the earnings announcement.

Merck & Co. announces financial results for first quarter 2020

In this challenging and unprecedented time, the quality of our first-quarter performance reflects strong demand for our portfolio of innovative products, continued commercial and clinical execution and the dedication and resilience of our employees around the world. The fundamentals of our business remain strong.

Kenneth C. Frazier, Chairman and CEO

You may also like:

COVID-19 puts insurers in tricky situation; risks range from litigation to insolvency

Ravaging almost every part of the world and crippling economic activity, the coronavirus pandemic has not spared any business. When it comes to the insurance industry, the nature of impact is complex and there is no doubt the companies will struggle with their underwriting decisions once the damage is fully assessed.

Check out our analysis 

Most Popular

Cost reduction has become a priority for FedEx (FDX) after a challenging quarter

Shares of FedEx Corporation (NYSE: FDX) were up 1% on Tuesday. The stock has dropped 44% year-to-date and 34% over the past 12 months. The company delivered mixed results for

Prime Medicine is the next big biotech to pursue IPO. Here’s all you need to know

After a soft start to the year, the IPO market has witnessed muted activity so far though a few big companies entered the stock market. On the heels of AIG

Stock Watch: Is Darden Restaurants a good buy after earnings?

After a prolonged slowdown, the restaurant industry is returning to normal patterns but macroeconomic uncertainties and high inflation are currently playing spoilsport for it. While the pandemic-related slump forced many

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top